Genomenon, Inc. — Form D
Genomenon, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-16. The offering totals $6.0M, of which $5.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-16
- Form: D
- Accession: 0001650557-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.5M
- Remaining: $538K
- Investors: 30
- Date of first sale: 2024-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513492
Issuer
- Name: Genomenon, Inc.
- CIK: 0001650557
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 206 E. Huron Street Suite 114, ANN ARBOR, MI, 48104
- Phone: 734-794-3075
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Patricia Glaza | Director | Ann Arbor, MI |
| David Gregorka | Director | Ann Arbor, MI |
| Michael Gross | Director | Ann Arbor, MI |
| Mark Kiel | Director | Ann Arbor, MI |
| Michael Klein | Director | Greenwich, CT |
| Sam Globus | Executive Officer | Ann Arbor, MI |
| Sean Kearney | Executive Officer | ANN ARBOR, MI |
| Mark Kiel | Executive Officer | Ann Arbor, MI |
| Michael Klein | Executive Officer | Greenwich, CT |
| Michael Gross | Related Person | Ann Arbor, MI |
| Michael Klein | Related Person | Greenwich, CT |
| Mark Kiel | Related Person | Ann Arbor, MI |
| Patricia Glaza | Related Person | Ann Arbor, MI |
| David Gregorka | Related Person | Ann Arbor, MI |
| Sam Globus | Related Person | Ann Arbor, MI |
| STEVE SCHWARTZ | Executive Officer | Kirkland, WA |
| Charles Moret | Director | ANN ARBOR, MI |
| Eli Salembier | Director | ANN ARBOR, MI |
| Eli Salembier | Executive Officer | ANN ARBOR, MI |
| Sonya Sepahban | Director | ANN ARBOR, MI |
| Brian Groark | Related Person | Ann Arbor, MI |
Other filings by this issuer (4)
More